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Abstract
Background: Montreal is Canada’s second-largest city, where mean annual tuberculosis (TB) incidence from 1996
to 2007 was 8.9/100,000. The objectives of this study were to describe the epidemiology of TB among homeless
persons in Montreal and assess patterns of transmission and sharing of key locations.
Methods: We reviewed demographic, clinical, and microbiologic data for all active TB cases reported in Montreal
from 1996 to 2007 and identified persons who were homeless in the year prior to TB diagnosis. We genotyped all
available Mycobacterium tuberculosis isolates by IS6110 restriction fragment length polymorphism (IS6110-RFLP) and
spoligotyping, and used a geographic information system to identify potential locations for transmission between
persons with matching isolates.
Results: There were 20 cases of TB in homeless persons, out of 1823 total reported from 1996-2007. 17/20 were
Canadian-born, including 5 Aboriginals. Homeless persons were more likely than non-homeless persons to have
pulmonary TB (20/20), smear-positive disease (17/20, odds ratio (OR) = 5.7, 95% confidence interval (CI): 1.7-20), HIV
co-infection (12/20, OR = 14, 95%CI: 4.8-40), and a history of substance use. The median duration from symptom
onset to diagnosis was 61 days for homeless persons vs. 28 days for non-homeless persons (P = 0.022). Eleven
homeless persons with TB belonged to genotype-defined clusters (OR = 5.4, 95%CI: 2.2-13), and ten potential
locations for transmission were identified, including health care facilities, homeless shelters/drop-in centres, and an
Aboriginal community centre.
Conclusions: TB cases among homeless persons in Montreal raise concerns about delayed diagnosis and ongoing
local transmission.
Background
As the overall incidence rate of tuberculosis (TB) in
Canada declined to 4.8 per 100,000 in 2008[1], the dis-
ease has become increasingly concentrated in cities and
among foreign-born populations and Aboriginal peoples
[2]. Homeless persons are also an important risk group
for TB, even in low incidence settings. Outbreaks
among homeless persons have been documented in
many North American cities over the past two decades
[3-6]. Health conditions among homeless persons, such
as HIV infection, substance abuse, and malnutrition,
may promote susceptibility to TB infection and progres-
sion to active TB disease. Homeless persons may
congregate in crowded and poorly ventilated buildings,
such as dormitories and shelters. They may have large
numbers of transient contacts, which are difficult to
characterize when tracking transmissible infection[7,8].
Moreover, homeless persons may present unique chal-
lenges for TB treatment and control with respect to
timely diagnosis, effective treatment, and successful con-
tact tracing and screening efforts.
The most recent census of homelessness in Montreal
was conducted in 1998[9]. Surveyors counted 28,214
unique persons who visited a homeless shelter, soup
kitchen, or drop-in centre during the year and of those,
12,666 had been without a fixed address in the past 12
months. A separate report estimated that the homeless
shelter capacity in Montreal was 1,187 beds[10]. To
date, there have been anecdotal reports of TB among
homeless persons in Montreal[11,12]. As this can have
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sought to describe the epidemiology of TB among
homeless persons in Montreal from 1996 to 2007,
including the extent of transmission within this group,
and to and/or from the non-homeless population.
Methods
Study setting
The Island of Montreal is Canada’s second largest city
and the largest city in the province of Quebec with a
population of 1.9 million. A single public health depart-
ment is responsible for TB notification and surveillance
on the Island of Montreal. By law, any physician who
m a k e sad i a g n o s i so fa c t i v eT Ba n da n yl a b o r a t o r yt h a t
identifies Mycobacterium tuberculosis (M. tuberculosis)
from a clinical specimen must report the case in nom-
inal form to the public health department. All M. tuber-
culosis isolates are sent to a single provincial reference
public health laboratory for confirmation and drug sus-
ceptibility testing. As of 2010, the estimated annual inci-
dence rate of TB for Montreal was 6.4 per 100,000[13]
Data collection and analysis
Our study used a retrospective, population-based cohort
design. We abstracted demographic, clinical, and micro-
biologic data from public health records for all persons
diagnosed with active TB in Montreal from January 1,
1996 to September 11, 2007. We also reviewed public
health records to abstract the results of contact investi-
gation and locations associated with cases. Homeless
persons were identified as individuals who had no per-
manent fixed address, were living outdoors or on the
street, or were residing in a shelter or temporary resi-
dence at any one time in the 12 months prior to their
diagnosis of TB. Individuals who were incarcerated at
the time of TB diagnosis and recently arrived refugees
living in dormitories such as the YMCA were not con-
sidered homeless for the purposes of our study, and
were included as members of the non-homeless group.
Individuals were characterized as users of tobacco, alco-
hol, and/or illicit drugs based on current use as docu-
mented in public health records, without a requirement
for minimum frequency or quantity of consumption.
To compare the characteristics of homeless and non-
homeless persons with TB, we performed univariate
logistic regression to estimate odds ratios for associations
with categorical variables, and applied a non-parametric
K-sample test on the equality of medians to compare
continuous variables. STATA SE v.8.0 (Stata Corp., Col-
lege Station, TX) was used for all statistical analyses.
Genotyping of Mycobacterium tuberculosis isolates
For all culture-positive cases, we used the standardized
methodology to genotype the corresponding M.
tuberculosis isolates by restriction fragment length poly-
morphism, based on the IS6110 insertion sequence
(IS6110-RFLP)[14]. Since IS6110-RFLP genotyping is
less reliable for isolates with fewer than six copies of the
IS6110 insertion sequence[15], we also used spoligotyp-
ing as a secondary method to characterize these “low-
copy” isolates[16].
For isolates with 6 or more copies of the IS6110 inser-
tion sequence ("high-copy” isolates), a cluster was
defined as two or more isolates with identical genotypes
by IS6110-RFLP. For isolates with fewer than 6 copies
of IS6110-RFLP, a cluster was defined as two or more
isolates with identical genotypes by IS6110-RFLP and
spoligotyping. For IS6110-RFLP, we used computer-
assisted matching of the resulting banding patterns with
GelCompar II (Applied Maths NV, Belgium), followed
by visual confirmation of suspected matches. Cases that
were members of the same cluster were considered part
of a TB transmission chain.
Geo-coding and mapping
We abstracted locations associated with TB cases and
contact investigations, as documented in records
assembled and held by the public health department.
Locations were captured by street address and six-digit
postal code, which describes a single block face or a
large apartment building. We verified that street
addresses corresponded to the correct postal codes
using Canada Post directories. We used ArcGIS v.9.3
(ESRI Inc, Redlands, CA) to map locations associated
with homeless persons with TB, and identify locations
shared by homeless and non-homeless persons with TB.
Ethical Considerations
This study was approved by the research ethics commit-
tees of the McGill University Faculty of Medicine and
the Montreal public health department.
Results
Incidence of TB
We identified 20 cases of TB in homeless persons, out of a
total of 1823 cases of active TB reported in Montreal from
January 1, 1996 to September 11, 2007. Based on the 1998
count of homeless persons in Montreal, the estimated
annual TB incidence in this group was 13.2 per 100,000.
During the same period, the estimated mean annual TB
incidence in the total population was 8.9 per 100,000.
Demographic and clinical characteristics of homeless
persons with TB
While non-homeless persons with TB in Montreal were
predominantly foreign-born (83%), 17/20 (85%) home-
less persons with TB were Canadian-born (OR = 28,
95% CI: 8.1-96) (Table 1). Furthermore, 5/17 homeless
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Page 2 of 10persons with TB who were born in Canada were Abori-
ginal, including 4 Inuit. There were 11 males and 9
females, and their median age at the time of diagnosis
was 44 years.
Homeless persons with TB were significantly more
likely than others to have contagious disease at the time
of diagnosis, and to have documented risk factors and
co-morbidities. All 20 homeless persons with TB had
pulmonary disease, of whom 17 (85%) had smear-positive
disease (OR = 5.7, 95% CI: 1.7-20). Two had concomitant
extrapulmonary disease (both miliary). The median time
from symptom onset to diagnosis was 61 days for home-
less persons, vs. 28 days for others (P = 0.022).
Of those tested for HIV, 12/17 (71%) homeless per-
sons with TB were HIV-positive, vs. 130/883 (15%) non-
homeless persons with TB (OR = 14, 95% CI: 4.8-40). In
addition, homeless persons with TB had higher preva-
lences of smoking, alcohol and drug use.
Results of contact investigations
For the 20 homeless persons with TB, potential contacts
were identified by public health authorities by name or
based on shared locations (eg. homeless shelters). There
were a total of 345 contacts identified; 183 (53%) were
shelter users or employees. Of the 345 contacts, 156
(45%) underwent tuberculin skin testing (TST). Of those
tested, 53 were TST positive, and 18 were prescribed
isoniazid for latent TB infection.
Two of the 20 homeless persons with active TB were
identified by public health authorities as contacts of a
non-homeless person with TB who attended an Aborigi-
nal community centre. One of these homeless indivi-
duals had an M. tuberculosis genotype that matched
that of the initial case, while the other had a distinct M.
tuberculosis genotype. There were two other non-home-
less persons with active TB (one distinct, one matching
the initial case by genotyping) who also attended the
Aboriginal community centre, for a total of 5 cases of
active TB identified in a 1-year period among indivi-
duals who frequented the community centre. Further
information on genotyping and sharing of locations is
provided below. None of the other 18 homeless persons
with active TB were prospectively identified by public
health authorities through contact investigations.
Table 1 Demographic and clinical characteristics of homeless and non-homeless persons with TB on the Island of
Montreal, 1996-2007
Homeless (n = 20) Non-Homeless (n = 1803) Odds Ratio or P-Value
Demographics
Canadian-born, N (%) 17 85% 297 16% OR = 28 (95% CI: 8.1-96)
Aboriginal, N (% of Canadian-born) 5 29% - - -
Median Age, Years (IQR) 44 35-51 39 28-60 p = 0.18
Male, N (%) 11 55% 974 53% OR = 1.0 (95% CI: 0.42-2.5)
TB Disease
Culture-Positive, N (% of all cases) 20 100% 1598 89% -
Pulmonary TB, N (% of all cases) 20 100% 1230 68% -
Smear-Positive, N (% of pulmonary cases) 17 85% 601 49% OR = 5.7 (95% CI: 1.7-20)
Resistant to one or more Drugs, N (%) 2 10% 211 12% OR = 0.71 (95% CI: 0.16-3.1)
Risk Factors and Co-morbidities
Smoker, N (%) 12 60% 274 15% OR = 8.2 (95% CI: 3.1-22)
Alcohol Use, N (%) 15 75% 271 15% OR = 20 (95% CI: 5.7-69)
Drug User, N (%) 13 65% 18 1.0% OR = 190 (95 % CI: 62-600)
Smoker and Alcohol and Drug User, N (%) 7 35% 11 0.61% OR = 86 (95% CI: 28-260)
Tested for HIV, N (%) 17 85% 883 49% OR = 5.9 (95% CI: 1.7-20)
HIV-Positive, N (% of Tested for HIV) 12 60% 130 7.2% OR = 14 (95% CI: 4.8-40)
Liver Disease, N (%) 11 55% 118 6.5% OR = 24 (95% CI: 8.7-66)
Psychiatric Illness, N (%) 4 20% - -
Treatment
Median Diagnostic Delay*(Days), IQR 61 31-92 28 14-60 p = 0.022
Directly Observed Therapy (DOT), N (%) 14 70% 733 45% OR = 5.6 (95% CI: 1.6-20)
Median Duration of Therapy (Months), IQR 9 6-10.5 6 6-9 p = 0.623
Treatment Outcome: Cured, N (%) 15 75% 1465 81% OR = 0.56 (95% CI: 0.18-1.7)
Treatment Outcome: Died, N (%) 3 15% 116 6.4% OR = 2.5 (95% CI: 0.73-8.8)
IQR = Interquartile Range, OR = Odds Ratio, CI = Confidence Interval
*Diagnostic Delay = Time from onset of symptoms to diagnosis of TB
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All 20 homeless persons with TB had culture-positive
disease, and their isolates were all successfully geno-
typed. Three of these had fewer than six IS6110 copies,
and were also characterized by spoligotyping (Table 2).
Of the 1803 non-homeless persons with TB, 89% were
culture-positive and 95% of the culture-positive samples
were genotyped by IS6110-RFLP.
Isolates from 11/20 (55%) homeless persons with TB
matched those of at least one other TB case in Mon-
treal; they were significantly more likely to be part of
such clusters than non-homeless persons with TB (OR
=5 . 3 ,9 5 %C I :2 . 2 - 1 3 ) .T h e r ew e r ef o u rg e n o t y p e -
defined clusters which included homeless and non-
homeless persons with TB (Figure 1). The largest cluster
( 1 2c a s e s )i n c l u d e d8h o m e l e s sp e r s o n sa n d4n o n -
homeless person, spanning 11 years. Three smaller clus-
ters included 6 (1 homeless and 5 non-homeless), 6 (1
homeless and 5 non-homeless) and 2 cases (1 homeless
and 1 non-homeless) respectively. The first reported
case was a homeless person in two of the four clusters.
The median time span between consecutive cases within
these four clusters was between 0.63 and 2.9 years
(Table 3)
The 15 non-homeless persons with TB who shared M.
tuberculosis genotypes with homeless persons also
shared risk profiles, including alcohol use (7/15), drug
use (4/15), and HIV co-infection (6/15). The group was
predominantly Canadian-born (11/15), and the four for-
eign-born were not recent immigrants (median time
since arrival of 27 years). Two persons in Cluster 1 were
commercial sex workers (one homeless, one non-home-
less). One person in Cluster 4 did not meet our defini-
tion of homelessness, but had previously been homeless
and was a former cocaine user.
Potential places of transmission
Sixty-three distinct locations associated with the 20
homeless persons with TB were documented in public
health records. These were concentrated in downtown
Montreal; they included overnight shelters, drop-in cen-
tres and day programs, parks and other outdoor spots,
bars and social locations, health care facilities, and resi-
dential households (e.g. friends’ addresses, last place of
residence before becoming homeless; Figure 2).
According to public health records, twelve homeless
persons with TB used the services of more than one
shelter or day centre. Forty-five locations were described
as associated with only one homeless person each (Fig-
ure 3). Eighteen locations were common to two or more
persons, with one location shared by nine homeless per-
sons. This was a hospital, where three of those nine per-
sons shared matching M. tuberculosis isolates. The next
most common shared location was a homeless shelter
frequented by seven different homeless persons; none
shared matching M. tuberculosis isolates. Twelve of the
eighteen locations were shared by two or more homeless
persons diagnosed with TB within the same 12 months
o fo n ea n o t h e r .A l s oi n1 1o ft h e s e1 8i n s t a n c e s ,t h e
shared locations corresponded to shared M. tuberculosis
genotypes. Other than the hospital previously men-
tioned, these included an Aboriginal community centre,
two homeless shelters/drop-in centres, a residential
address suspected to be a site of drug injection, a bar,
and five other health care facilities.
Conversely, within the four genotype-defined clusters,
there were 13 locations shared by two or more members
of Cluster 1 (12 cases total), 3 shared within Cluster 2 (6
cases), none shared within Cluster 3 (2 cases), and 1
shared within Cluster 4 (6 cases). Most locations asso-
ciated with non-homeless cluster members were residen-
tial addresses. One of the locations shared by Cluster 2
members was the Aboriginal community centre; three
individuals (one homeless person, two non-homeless per-
sons) who attended the community centre were diag-
nosed with active TB within a 12-month period. This
prompted tuberculin skin testing and active case-finding
at the community centre, yielding two additional cases of
active TB (one homeless person, one non-homeless per-
son). In both these subsequent cases, the M. tuberculosis
genotypes were distinct from the earlier group.
Overall, twenty-two potential instances of transmission
between homeless and non-homeless persons with TB
were identified by genotyping. For twelve potential
transmission pairs, they shared at least one location
within 12 months of one another (Figure 4).
Discussion
Previous studies from Montreal have indicated that
most tuberculosis cases occur in foreign-born-persons,
Table 2 Genotyping results for homeless and non-homeless persons with TB on the Island of Montreal, 1996-2007
Homeless (n = 20) Non-Homeless (n = 1803) Odds Ratio or P-Value
TB Isolates Genotyped, % of Culture-Positive 20 100% 1521 95% -
High-copy* isolates, % of Genotyped 17 85% 1257 83% OR = 1.2 (95% CI = 0.35-4.1)
Genetically Clustered†, % of Genotyped 11 55% 286 19% OR = 5.3 (95% CI = 2.2-13)
*Isolates with 6 or copies of the IS6110 insertion sequence; matching ‘low-copy’ isolates were also characterized by spoligotype
†Identical to one or more isolate by IS6110-RFLP (and spoligotype if less than 6 bands)
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Figure 1 Genetic clusters with homeless and non-homeless persons with TB, Island of Montreal, 1996-2007.
Table 3 Temporal span of clusters with homeless persons with TB, Island of Montreal, 1996-2007
Genetic Cluster Median Duration between Consecutive
Cases, Years (IQR)
Duration between First and Last Case, Years
Cluster 1 (n = 12) 0.63 (0.20-1.1) 11
Cluster 2 (n = 6) 0.65 (0.35-0.94) 4.0
Cluster 3 (n = 2) 2.9 (-) 2.9
Cluster 4 (n = 6) 1.4 (0.42-2.6) 7.9
IQR = Interquartile Range
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Page 5 of 10and are associated with unique M. tuberculosis geno-
types, reflecting reactivation of latent infection acquired
abroad[12,17]. In contrast, homeless persons with TB in
Montreal were mostly Canadian-born, with contagious
disease and significant co-morbidities including HIV co-
infection. More than half shared M. tuberculosis geno-
types with others. Diagnostic delays and evidence of
transmission within and beyond the homeless popula-
tion remain a concern. As in other jurisdictions, our
findings highlight challenges in TB control for this
homeless population, and potential impacts on the sur-
rounding community.
One issue relates to health care access. Studies from
Toronto and Montreal have indicated that lack of iden-
tification papers and health insurance documentation is
an important barrier to health care (including TB care)
for homeless persons[10,18] and other marginalized
groups[19]. Moreover, seeking care for sub-acute or
chronic symptoms may take lower priority than basic
needs for food, shelter, and safety[20].
As in this study, genotyping studies elsewhere have
found homelessness to be a consistent predictor of TB
transmission in low-incidence settings[21]. In several
cities, ongoing TB transmission within homeless groups
and shelters continues to be a problem [3-6]. Interrupt-
ing TB transmission among homeless groups, as well as
among homeless and non-homeless groups, is a key
priority for public health intervention in urban settings
[22]. Toronto - Canada’s largest city - experienced an
outbreak of TB among 16 individuals at two large shel-
ters for homeless men in 2001-2002 and a subsequent
wave involving 2 shelter staff and 11 under-housed indi-
viduals. Genotyping results suggest that TB transmission
within Toronto’s under-housed population is ongoing
and has spread to individuals without evident links to
the shelter system[6].
While Toronto’s population (2.5 million) is roughly
30% greater than Montreal’s (1.9 million), Toronto also
reported more than four times the number of homeless
persons with TB (91 persons) during a time frame
 
Figure 2 Locations associated with homeless persons with TB on the Island of Montreal, 1996-2007.
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Page 6 of 10similar to that of our study[23]. The reasons for this dif-
ference are not entirely clear, but contributing factors
likely included 1) extensive transmission (documented
by M. tuberculosis genotyping), likely reflecting the high
prevalence of heavily smear-positive, cavitary disease;
and 2) an increasing proportion of foreign-born persons
(notably those from high TB incidence countries)
among homeless persons with TB in Toronto. By 2003-
2007, 39% of the Toronto homeless persons diagnosed
with active TB were foreign-born. If, more generally,
foreign-born persons from high TB incidence countries
account for a growing proportion of the homeless popu-
lation, this would result in a larger reservoir of latent
TB infection. In Montreal, only three of the 20 homeless
persons with TB were foreign-born and there was more
limited evidence of ongoing transmission.
In our small group of homeless persons with TB, most
were successfully treated. The authors of a national sur-
vey of homelessness and tuberculosis in the United
States reviewing 10 years of surveillance data concluded
that despite risk factors for both the development of TB
and for poorer outcomes (substance abuse, past incar-
ceration, HIV co-infection), treatment was usually suc-
cessful for homeless persons with TB[24]. Success was
enhanced by effective case management and appropriate
drug regimen.
Contact investigation, tuberculin skin testing, and fol-
low-up can be particularly challenging once exposure
has occurred, as the experience of the Aboriginal com-
munity centre illustrates[19]. Indeed, in Montreal, there
have been some successes but also substantial challenges
in conducting contact investigations among users of
shelters and drop-in centres[19,25]. One intervention at
a Montreal shelter used monetary incentives to encou-
rage individuals to complete tuberculin skin testing, sub-
sequent evaluation and treatment[25], as also reported
elsewhere[26,27].
Directly observed preventive therapy is another poten-
tial approach to enhance treatment of latent TB infec-
tion, in order to prevent progression to active disease.
An appealing new option in this respect is the three-
month weekly regimen of isoniazid and rifapentine,
which is likely an acceptable alternative to the tradi-
tional nine-month course of daily isoniazid [28]. It is
possible that appropriate use of enablers and incentives
could further enhance the success of this approach.
However, treatment of latent infection for homeless per-
sons may remain challenging, because of difficulty
reaching and following these individuals, and also
because of concomitant substance use which places indi-
viduals at higher risk of adverse treatment effects.
Overall, our study adds to the consensus that home-
less persons are a risk group for TB and TB transmis-
sion in urban settings. The key question is how to
respond effectively. Reported interventions have
included a mobile radiographic screening program in
Rotterdam[29], and improved ventilation plus ultraviolet
light fixtures in a shelter in St. Louis[30]. Improvements
to the management of latent TB infection would like-
wise be important in this context. Our findings of
shared M. tuberculosis genotypes among users of hospi-
tals and other health facilities, a community centre, and
homeless shelters suggest that infection control mea-
sures may need further improvement, e.g. prompt iden-
tification, evaluation, diagnosis, and isolation of persons
with potential TB-related symptoms. We recognize that
these health care facilities included those most often
used by homeless persons and by individuals with tuber-
culosis in central Montreal; we did not have usage
records to detect possible shared dates of attendance.
Strengths of this study include its long duration and the
completeness of M. tuberculosis public health and geno-
typing data, allowing us to capture community experience
over many years. We were able to identify an extended
chain of TB transmission involving homeless and non-
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Figure 3 Flow chart of locations associated with homeless
persons with TB on the Island of Montreal, 1996-2007.
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Page 7 of 10homeless cases. A formal social network analysis was
beyond the scope of this manuscript. However, the limits
of investigation based on named contacts have been well
recognized in the context of homeless and other margina-
lized populations[11], which was why we elected to focus
on named locations rather than named individuals.
Our study was also limited by its retrospective design.
In recent years, the public health department’s investiga-
tions and questionnaires have become more focused on
TB among under-housed or homeless individuals, and
personnel have more aggressively sought to identify loci
for transmission outside the traditional household[11].
 
Location 
Genetic 
Cluster  Year of Cases   Cases 
1  Hospital  Cluster 1  1996-1997  Homeless Case 1 - Non-homeless Case 1 
2  Health clinic  Cluster 1  2003-2003  Homeless Case 2 - Homeless Case 3 
3  Suspected drug 
injection site  Cluster 1  2003-2003  Homeless Case 2 - Homeless Case 3 
4  Hospital  Cluster 1  2005-2005  Homeless Case 4 - Non-homeless Case 3  
5  Homeless shelter  Cluster 1  2005-2005  Homeless Case 4 - Homeless Case 5 
6  Health clinic  Cluster 1  2005-2006  Homeless Case 4 - Homeless Case 6 
7  HIV/AIDS clinic  Cluster 1  2005-2006-
2006 
Homeless Case 4 - Homeless Case 6 - 
Homeless Case 8  
8  Hospital  Cluster 1  2003-2003  Homeless Case 2 - Non-homeless Case 2 
8  Hospital  Cluster 1  2006-2006  Homeless Case 7 - Homeless Case 8 
8  Hospital  Cluster 2  1999-1999-
2000 
Non-homeless Case 4 - Non-homeless Case 5 
- Non-homeless Case 6 
9  Hospital  Cluster 2  2002-2002-
2003 
Non-homeless Case 7 - Non-homeless Case 8 
- Homeless Case 9 
10  Aboriginal 
community centre 
Cluster 2  2002-2002-
2003 
Non-homeless Case 7 - Non-homeless Case 8 
- Homeless Case 9 
Figure 4 Potential places of transmission for genetically clustered homeless and non-homeless persons with TB on the Island of
Montreal, 1996-2007.
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Page 8 of 10This may partly explain the relatively limited numbers
of homeless persons with TB and shared locations iden-
tified. Our study was designed to identify homeless per-
sons with a confirmed diagnosis of TB and as such,
some may have been missed if they experienced barriers
to seeking care. Additionally, public health personnel
may have verified certain risk factors differently in
homeless persons, which could have emphasized differ-
ences in HIV co-infection, substance use, and related
attributes. It is also entirely possible that the 1998 sur-
vey of Montreal’s homeless population is outdated, mak-
ing the denominator of our incidence estimate
inaccurate.
Conclusions
Our findings raise concerns about delays in TB diagno-
sis and ongoing transmission within and beyond this
homeless population. There clearly remain important
opportunities for innovative health care interventions
and operational research to better address the challenges
of TB prevention and control among homeless persons
in low-incidence settings.
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